Intervention Review

Tegaserod for the treatment of irritable bowel syndrome and chronic constipation

  1. Beti W Evans1,*,
  2. Wendy K Clark2,
  3. David J Moore3,
  4. Peter J Whorwell4

Editorial Group: Cochrane IBD Group

Published Online: 17 OCT 2007

Assessed as up-to-date: 30 JUL 2007

DOI: 10.1002/14651858.CD003960.pub3

How to Cite

Evans BW, Clark WK, Moore DJ, Whorwell PJ. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD003960. DOI: 10.1002/14651858.CD003960.pub3.

Author Information

  1. 1

    University of Hertfordshire, School of Pharmacy, Hatfield, UK

  2. 2

    Keele University, Medicines Management, Newcastle-under-Lyme, Staffordshire, UK

  3. 3

    University of Birmingham, Aggressive Research Intelligence Facility, University of Birmingham, West Midlands, UK

  4. 4

    Wythenshawe Hospital, Medical Academic Department, Manchester, UK

*Beti W Evans, School of Pharmacy, University of Hertfordshire, College Lane Campus, Hatfield, AL10 9AB, UK.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 17 OCT 2007


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.